-
Benzinga’s Earnings Roundup (AN, VIA, MAR, PGN)
Thursday, February 11, 2010 - 9:07am | 294AutoNation, Inc. (NYSE: AN) reported today a fourth-quarter net income of $61.7 million, or $0.35 per share, as compared to $67.1 million, or $0.38 per share, for the same quarter last year. Total revenue increased to $2.8 billion as compared to $2.6 billion in the year ago period. Analysts...
-
Stock Market News for February 9, 2010 - Market News
Tuesday, February 9, 2010 - 10:15am | 473Stocks took another plunge Monday with the Dow average closing below 10,000 for the first time in three months as lingering worries about European government finances and a potential regulation spooked investors. In a sign that sentiments remain jittery, some better-than-expected profit reports...
-
Celgene Beats Zacks Estimate - Analyst Blog
Friday, January 29, 2010 - 2:44pm | 419This morning, Celgene Corp. (CELG) reported fourth quarter and full year results for fiscal 2009. Quarterly Results The company earned 62 cents per share in the fourth quarter as opposed to 43 cents in the year-ago quarter. The Zacks Consensus Estimate for the quarter was 57 cents. Total...
-
Auto Parts Retail Industry Update (ORLY, GPC, AZO, AAP)
Monday, January 25, 2010 - 3:36pm | 217Analysts at FBR Capital Markets Corporation (NASDAQ: FBCM) have released an update on the Auto Parts Retail industry. Analysts have upgraded the shares of O’Reilly Automotive Inc. (NASDAQ: ORLY) from Underperform to Outperform. The shares of Genuine Parts Company (NYSE: GPC) meanwhile have been...
-
Benzinga’s Top Upgrades (OSG, DSPG, NAT, ORLY, EGLE)
Monday, January 25, 2010 - 10:20am | 282Overseas Shipholding Group Inc. (NYSE: OSG) was upgraded today by Cantor Fitzgerald from Sell to Buy. Overseas Shipholding Group is now trading at $45.50, 2.89% up in the pre-market session. Overseas Shipholding Group closed at $44.22 in the previous trading session. In the last year, OSG has...
-
Celgene Expands in Cancer Drugs - Analyst Blog
Monday, January 18, 2010 - 3:01pm | 462Recently, Celgene Corporation (CELG) completed the acquisition of the privately held Gloucester Pharmaceuticals for $340 million in cash coupled with $300 million in future milestone payments. The deal is aimed at bolstering Celgene’s portfolio of cancer drugs. The deal is expected to be neutral...
-
Good News for Celgene - Analyst Blog
Wednesday, January 13, 2010 - 6:49pm | 379Yesterday, Celgene Corporation (CELG) announced that its cancer drug Revlimid met the main goal in a randomized, double-blind, multi-center late-stage study (IFM 2005 02). The study, sponsored by the Intergroupe Francophone du Myelome and University Hospital of Toulouse, evaluated Revlimid compared...
-
AAP Lacks Near Term Catalysts
Tuesday, January 12, 2010 - 1:51pm | 128Analysts at RBC Capital Markets downgrade Advance Auto Parts Inc (NYSE: AAP) from "top pick" to "outperform." The target price for AAP has been reduced from $51 to $48. O'Reilly’s stock offers modestly better risk/reward profile as compared to Advance Auto Parts, although the latter has reported...
-
Celgene Scores with Revlimid - Analyst Blog
Monday, December 21, 2009 - 3:34pm | 348Celgene Corporation (CELG) announced recently that initial results from a late-stage study in multiple myeloma (MM) patients revealed that those treated with Revlimid underwent a 58% reduction in disease progression compared to placebo. The positive results caused shares of Celgene to close Dec...
-
Goldman Sachs (GS) Lifts CarMax Inc (KMX)
Monday, December 21, 2009 - 2:34pm | 129Goldman Sachs (NYSE: GS) raised its earnings estimates for CarMax Incorporation (NYSE: KMX) as the company’s 3Q2009 results showcased resilient used car profitability and strong cost controls. The EPS of $0.33 vs. a loss of $0.09 a year earlier sharply exceeded expectations, with the beat driven...
-
Company News for December 18, 2009 - Corporate Summary
Friday, December 18, 2009 - 10:04am | 216• Research in Motion (NASDAQ:RIMM) posted strong results and gave a strong guidance as quarterly earnings reached $1.10 in the third quarter, up from 69 cents a year ago and Zacks estimates of $1.04. The firm said it sees fourth-quarter earnings of $1.23 to $1.31 a share, with revenues projected at...
-
Benzinga’s Earnings Roundup (KMX, ROSG, RIMM, PALM)
Friday, December 18, 2009 - 9:50am | 344CarMax, Inc (NYSE: KMX) today reported a third-quarter profit of $74.6 million as compared to a loss of $21.9 million in the year ago period. Analysts on an average expected CarMax to earn $0.16 a share on sales of $1.63 billion. CarMax is currently trading trading at $23.70, increased by 8.62% in...
-
Benzinga's Earnings Preview (CCL, KMX, STEI, ROSG, LIVE)
Friday, December 18, 2009 - 5:33am | 179Carnival Corporation (NYSE: CCL) is expected to report fiscal fourth-quarter earnings of 20 cents a share on revenue of $3.20 billion. Thursday, CCL closed at $33.36. CarMax, Inc (NYSE: KMX) is projected to report fiscal third-quarter earnings of 16 cents a share on $1.66 billion of revenues. In...
-
Company News for December 17, 2009 - Corporate Summary
Thursday, December 17, 2009 - 10:00am | 366• UBS (NYSE:UBS) began coverage of Bank of America (NYSE:BAC) with a "buy" rating after the company named Brian Moynihan as its new CEO • General Mills (NYSE:GIS) posted fiscal second quarter earnings of $1.54 a share, versus Zacks estimates of $1.45 a share on sales of $4.08 billion. Citing first...
-
MNRO: Keep Your Portfolio Chugging Along With Monro Muffler Brake
Wednesday, December 16, 2009 - 6:19pm | 570Some experts think the U.S. economy is beginning to show signs of recovery. Possibly, but with so many folks still unemployed and access to credit at its lowest levels in years, consumers and businesses alike are tightening their purse strings. Over the past year, we’ve highlighted frugalpalooza...